D John Ratliff

Ceo, Covance Drug Development at Laboratory Corp Of America Holdings (LH), 2019-04-05
President And Coo at Quintiles Transnational Holdings Inc. (Q), 2013-11-19

Insider Trading: Sales See All

Symbol	Price	Amount	Total Value	Remaining Holdings	Date	Form 4
Q	$42.55	97,140	$4,133,307.00	0	2013-11-18	Filing
Q	$42.55	115,000	$4,893,250.00	0	2013-11-18	Filing